Evaluation of epidermal growth factor receptor gene and chromosome 7 alterations in squamous cell carcinoma of the larynx, using chromogenic in situ hybridization on tissue microarrays

Journal of Laryngology and Otology

Volumn 121, Issue 6, 2007, Pages 563-570

  Tsiambas, E ^a,d   Stavrakis, I ^b   Lazaris, A C ^c   Karameris, A ^a   Patsouris, E ^c  

^a Veterans Administration Hospital NIMTS   (Greece)

^b GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d NONE   (Greece)

Author keywords

Carcinoma; Chromosomes; Epidermal Growth Factor; Genes; Hybridisation; Larynx; Nucleic Acid; Receptor; Squamous Cell

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FORMALDEHYDE; PARAFFIN;

ADULT; ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME 7; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARYNX CARCINOMA; MALE; PATHOLOGY; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TISSUE MICROARRAY;

CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; GENES, ERBB-1; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PATIENT SELECTION; TISSUE ARRAY ANALYSIS;

EID: 34249057112     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215106002374     Document Type: Article

References (31)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-94
2. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33
3. Do KA, Johnson MM, Lee JJ, Wu XF, Dong Q, Hong WK et al. Longitudinal study of smoking-related secondary primary tumours in patients with upper aero-digestive tract malignancies. Cancer 2004;101:2837-42
4. Sturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patients. Anal Otol Rhinol Laryngol 1995;104:946-54
5. Albertson D, Collins C, McCormick F, Gray J. Chromosome aberrations in solid tumours. Nat Genet 2003;34:369-76
6. Wu R, Abramson AL, Shikowitz MJ, Dannenberg AJ, Steinberg BM. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas. Clin Cancer Res 2005;11:6155-61
7. Veltman JA, Bot FJ, Huynen FC, Ramaekers FC, Manni JJ, Hopman AH. Chromosome instability as an indicator of malignant progression in laryngeal mucosa. J Clin Oncol 2000;18:1644-51
8. Ulrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-12
9. Marquez A, Wu R, Zhao J, Tao J, Shi Z. Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy. Diagn Mol Pathol 2004;13:1-8
10. Wiedmann MW, Casa K. Molecular targeted therapy for gastrointestinal cancer. Curr Cancer Drug Targets 2005;5:171-93
11. Ang K, Berkey X. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002;62:7350-6
12. Park K, Kim J, Lim S, Han S, Lee JY. Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray. Mod Pathol 2003;16:937-43
13. Zhao J, Wu R, Au A, Marquez A, Yu Y, Shi Z. Determination of topoisomerase IIa gene amplification by chromogenic in situ hybridization in archival breast carcinoma. Mod Pathol 2002;15:657-65
14. Stoecklein NL, Luebke AM, Erbersdobler A, Knoefel WT, Schraut W, Verde PE et al. Copy number of chromosome 17 but not HER2/neu amplification predicts clinical outcome of patients with pancreatic ductal adenocarcinoma. J Clin Oncol 2004;22:4737-45
15. Koynova DK, Tsenova VS, Jankova RS, Gurov PB, Toncheva DI. Tissue microarray analysis of EGFR and HER2 oncogene copy number alterations in squamous cell carcinoma of the larynx. J Cancer Res Clin Oncol 2005;131:199-203
16. Fu Z, Wang J. The expression of epidermal growth factor receptor mRNA in the laryngeal squamous cell carcinoma with northern blot. Lin Chuang Er Pi Yen Hou Ko Tsa Chih 2002;16:648-9
17. Moroni M, Veronese S, Benvenuti S, Marrapese G, Sartore-Bianchi A, Di Nicolantonio F et al. Gene copy number for epidermal growth factor receptor EGFR and clinical response to anti-EGFR treatment in colorectal cancer: a cohort study. Lancet Oncol 2005;6:279-86
18. Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998;90:824-32
19. Robert F, Ezekiel MP, Spencer SA, Meredith RF, Bonner JA, Khazaeli MB et al. Phase I study of antiepidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol 2001;19:3234-43
20. Shin DM, Donato NJ, Perez-Soler R, Shin HJ, Wu JY, Zhang P et al. Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. Clin Cancer Res 2001;7:1204-13
21. Baselga J, Trigo J, Bourhis J. Cetuximab plus cisplatin/carboplatin is active in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing on a same dose and schedule platinum-based regimen. Proc Am Soc Clin Oncol 2000;21:226a
22. Gale N, Kambic V, Poljak M, Cor A, Velkavrh D, Mlacak B. Chromosomes 7,17 polysomies and overexpression of epidermal growth factor receptor and p53 protein in epithelial hyperplastic laryngeal lesions. Oncology 2000;58:117-25
23. Morrison LE, Jacobson KK, Friedman M, Schroeder JW, Coon JS. Aberrant EGFR and chromosome 7 associate with outcome in laryngeal cancer. Laryngoscope 2005;115:1212-18
24. Veltman JA, van Weert I, Aubele M, Bot FJ, Ramaekers FC, Manni JJ et al. Specific steps in aneuploidization correlate with loss of heterozygosity of 9p21, 17p13 and 18q21 in the progression of pre-malignant laryngeal lesions. Int J Cancer 2001;15,91:193-9
25. Chen B, van den Brekel MW, Buschers W, Balm AJ, van Velthuysen ML. Validation of tissue array technology in head and neck squamous cell carcinoma. Head Neck 2003;25:922-30
26. Rubin MA, Dunn R, Strawderman M, Pienta KJ. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002;26:312-19
27. Camp RL, Dolled-Filhart M, King BL, Rimm DL. Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2/neu expression are associated with poor outcome. Cancer Res 2003;63:1445-8
28. Gil J, Wu H, Wang B. Image analysis and morphometry in the diagnosis of breast cancer. Microsc Res Tech 2002;59:109-18
29. Ueda S, Ogata S, Tsuda H, Kawarabayashi N, Kimura M, Sugiura Y et al. The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma. Pancreas 2004;29:e1-8
30. Luzar B, Poljak M, Fischinger J, Klopcic U, Gale N. Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study. J Laryngol Otol 2005;119:917-21
31. Quon H, Liu FF, Cummings BJ. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 2001;23:147-59